Diagnostic Imaging's Weekly Scan: January 1-January 7

Recently published research projected that 103,000 future cases of radiation-induced cancer would result from 93 million computed tomography (CT) exams performed in the United States in 2023.

In the third episode of a three-part podcast, Anand Narayan, M.D., Ph.D., and Amy Patel, M.D., discuss the challenges of expanded breast cancer screening amid a backdrop of radiologist shortages and ever-increasing volume on radiology worklists.

Seniors who had at least one prior screening mammography exam in the five years prior to breast cancer diagnosis were over a third less likely to die from breast cancer, according to new research.

In the second episode of a three-part podcast, Anand Narayan, M.D., Ph.D., and Amy Patel, M.D., discuss recent studies published by the Journal of the American Medical Association (JAMA) that suggested moving to more of a risk-adapted model for mammography screening.

The additional FDA 510(k) clearance for the AI-powered cmAngio platform covers use of the software for GE HealthCare mammography systems.

An emerging nomogram model for intra-tumoral heterogeneity quantification with breast MRI demonstrated an average 85 percent sensitivity in external validation testing for predicting pathologic complete response to neoadjuvant chemotherapy for breast cancer.